Stem cell-based therapies for polyglutamine diseases
Polyglutamine (polyQ) diseases are a family of neurodegenerative disorders with very
heterogeneous clinical presentations, although with common features such as progressive …
heterogeneous clinical presentations, although with common features such as progressive …
Ex situ bioengineering of bioartificial endocrine glands: a new frontier in regenerative medicine of soft tissue organs
R Toni, A Tampieri, N Zini, V Strusi, M Sandri… - Annals of Anatomy …, 2011 - Elsevier
Ex situ bioengineering is one of the most promising perspectives in the field of regenerative
medicine allowing for organ reconstruction outside the living body; ie on the laboratory …
medicine allowing for organ reconstruction outside the living body; ie on the laboratory …
Organization of the human fetal subpallium
MC Pauly, MD Döbrössy, G Nikkhah… - Frontiers in …, 2014 - frontiersin.org
The subpallium comprises large parts of the basal ganglia including striatum and globus
pallidus. Genes and factors involved in the development of the subpallium have been …
pallidus. Genes and factors involved in the development of the subpallium have been …
Regenerative medicine in Huntington's disease: current status on fetal grafts and prospects for the use of pluripotent stem cell
AC Bachoud-Lévi, AL Perrier - Revue neurologique, 2014 - Elsevier
Huntington's disease is currently incurable, but cell therapy is seen as a promising
alternative treatment. We analyze the safety and efficacy of the intrastriatal transplantation of …
alternative treatment. We analyze the safety and efficacy of the intrastriatal transplantation of …
Multifaceted roles of BDNF and FGF2 in human striatal primordium development. An in vitro study
E Sarchielli, M Marini, S Ambrosini, A Peri… - Experimental …, 2014 - Elsevier
Grafting fetal striatal cells into the brain of Huntington's disease (HD) patients has raised
certain expectations in the past decade as an effective cell-based-therapy for this …
certain expectations in the past decade as an effective cell-based-therapy for this …
Installation of a Neuromate robot for stereotactic surgery: Efforts to conform to Japanese specifications and an approach for clinical use—Technical notes
Y Kajita, D Nakatsubo, H Kataoka, T Nagai… - Neurologia medico …, 2015 - jstage.jst.go.jp
The neuromate is a commercially available, image-guided robotic system for use in
stereotactic surgery and is employed in Europe and North America. In June 2015, this …
stereotactic surgery and is employed in Europe and North America. In June 2015, this …
[HTML][HTML] Human pluripotent stem cell therapy for Huntington's disease: technical, immunological, and safety challenges
C Nicoleau, P Viegas, M Peschanski, AL Perrier - Neurotherapeutics, 2011 - Elsevier
Intra-striatal transplantation of homotypic fetal tissue at the time of peak striatal neurogenesis
can provide some functional benefit to patients suffering from Huntington's disease …
can provide some functional benefit to patients suffering from Huntington's disease …
The current status of neural grafting in the treatment of Huntington's disease. A review
R Wijeyekoon, RA Barker - Frontiers in integrative neuroscience, 2011 - frontiersin.org
Huntington's disease (HD) is a devastating, fatal, autosomal dominant condition in which the
abnormal gene codes for a mutant form of huntingtin that causes widespread neuronal …
abnormal gene codes for a mutant form of huntingtin that causes widespread neuronal …
Revisiting cell and gene therapies in Huntington's disease
M Beatriz, C Lopes, ACS Ribeiro… - Journal of …, 2021 - Wiley Online Library
Neurodegenerative movement disorders, such as Huntington's disease (HD), share a
progressive and relentless course with increasing motor disability, linked with …
progressive and relentless course with increasing motor disability, linked with …
Stem cell therapy for the central nervous system in lysosomal storage diseases
F Siddiqi, JH Wolfe - Human Gene Therapy, 2016 - liebertpub.com
Neurological diseases with genetic etiologies result in the loss or dysfunction of neural cells
throughout the CNS. At present, few treatment options exist for the majority of neurogenetic …
throughout the CNS. At present, few treatment options exist for the majority of neurogenetic …